Esya is a biotech company that measures, monitors, assist drug development, and pre-assess patient cohorts for treatment.
Esya has raised $452K in total funding. The most recent round was Grant. The last funding was announced in November 2022.
Esya's investors include Michael J. Fox Foundation, George Shultz Innovation Fund.
Esya is headquartered in Newbury, United Kingdom.
Esya is a biotech company that measures, monitors, assist drug development, and pre-assess patient cohorts for treatment.
Esya is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Esya — Funding & Investors." VCBacked, November 4, 2022, https://www.vcbacked.co/company/esya. Accessed August 17, 2026.
VCBacked. (2022). Esya — Funding & Investors. Retrieved August 17, 2026, from https://www.vcbacked.co/company/esya
{{cite web |title=Esya — Funding & Investors |url=https://www.vcbacked.co/company/esya |website=VCBacked |access-date=August 17, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated